Expand VATE Menu
VATE MENU

VATE Stock Posts


VATE #InnovateCorp. stock increases 57.9% after hours.

After Hours Gainer

VATE Innovate Corp.5.11+0.23+4.7%

After Hours:8.07+2.96 (+57.9%)

MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Globe NewswireFri, 17-Jan 6:18 PM
VATE #InnovateCorp. stock increases 40.5% after hours.

After Hours Gainer

VATE Innovate Corp.5.11+0.23+4.7%

After Hours:7.18+2.07 (+40.5%)

MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Globe NewswireFri, 17-Jan 6:18 PM
Upcoming Earnings

VATE Innovate Corp.5.43+0.34 (+6.7%)

Innovate Corp. will report earnings after the market closes. View Calendar The market is expecting a ±16.0% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.6%. View Expected Move (Conf Call: Nov 6 4:30 PM)
Upcoming Earnings

VATE Innovate Corp.0.610.00 (+0.3%)

Innovate Corp. will report earnings after the market closes. View Calendar The market is expecting a ±14.4% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.8%. View Expected Move (Conf Call: Aug 7 4:30 PM)
Upcoming Earnings

VATE Innovate Corp.0.74-0.01 (-1.9%)

Innovate Corp. will report earnings after the market closes. View Calendar The market is expecting a ±15.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±15.2%. View Expected Move (Conf Call: May 7 4:30 PM)
Upcoming Earnings

VATE Innovate Corp.0.80+0.01 (+1.3%)

Innovate Corp. will report earnings after the market closes. View Calendar The market is expecting a ±16.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±10.5%. View Expected Move (Conf Call: Mar 4 4:30 PM)
Load Earlier Posts